CDK4/6 as a therapeutic target in malignant melanoma

被引：0
|
作者：
Teh, Jessica L. [1 ]
Aplin, Andrew [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3096
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Precision Oncology Platform to Target CDK4/6 Inhibitor Resistance
    Pandey, K.
    Udden, N.
    Alluri, P. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S45 - S45
  • [32] Therapeutic targeting of CDK4/6 inhibitor resistant breast cancer
    Lim, Elgene
    Portman, Neil
    Alexandrou, Sarah
    Haupt, Susan
    Haupt, Ygal
    Caldon, Elizabeth
    CANCER RESEARCH, 2018, 78 (04)
  • [33] Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition
    Dean, Jeffry L.
    McClendon, A. Kathleen
    Knudsen, Erik S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (34) : 29075 - 29087
  • [34] Mechanisms of resistance to CDK4/6 inhibitors and new therapeutic approaches
    Chandarlapaty, S.
    CANCER RESEARCH, 2020, 80 (04)
  • [35] CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
    Stice, James P.
    Wardell, Suzanne E.
    Norris, John D.
    Yllanes, Alexander P.
    Alley, Holly M.
    Haney, Victoria O.
    White, Hannah S.
    Safi, Rachid
    Winter, Peter S.
    Cocce, Kimberly J.
    Kishton, Rigel J.
    Lawrence, Scott A.
    Strum, Jay C.
    McDonnell, Donald P.
    MOLECULAR CANCER RESEARCH, 2017, 15 (06) : 660 - 669
  • [36] Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
    Wu, Yanmei
    Zhang, Yu
    Pi, Hao
    Sheng, Yuan
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3477 - 3487
  • [37] Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
    Sager, Rebecca A.
    Backe, Sarah J.
    Ahanin, Elham
    Smith, Garrett
    Nsouli, Imad
    Woodford, Mark R.
    Bratslaysky, Gennady
    Bourboulia, Dimitra
    Mollapour, Mehdi
    NATURE REVIEWS UROLOGY, 2022, 19 (05) : 305 - 320
  • [38] Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
    Rebecca A. Sager
    Sarah J. Backe
    Elham Ahanin
    Garrett Smith
    Imad Nsouli
    Mark R. Woodford
    Gennady Bratslavsky
    Dimitra Bourboulia
    Mehdi Mollapour
    Nature Reviews Urology, 2022, 19 : 305 - 320
  • [39] A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target
    Franceschini, Natasja
    Gaeta, Raffaele
    Krimpenfort, Paul
    Briaire-de Bruijn, Inge
    Kruisselbrink, Alwine B.
    Szuhai, Karoly
    Cleton-Jansen, Anne-Marie
    Bovee, Judith V. M. G.
    PalubeckaiteQ, Leva
    LABORATORY INVESTIGATION, 2022, 102 (04) : 391 - 400
  • [40] Inducible deletion of CDK4 and CDK6-deciphering CDK4/6 inhibitor effects in the hematopoietic system
    Maurer, Barbara
    Brandstoetter, Tania
    Kollmann, Sebastian
    Sexl, Veronika
    Prchal-Murphy, Michaela
    HAEMATOLOGICA, 2021, 106 (10) : 2624 - 2632
12345